A New Approach to Vision Therapy Based on Naturalistic 3-D Computer Gaming
ICARE
1 other identifier
interventional
92
1 country
1
Brief Summary
The research team will execute two concurrent studies within a common framework. The first will compare iCare to standard of care occlusion therapy (patching) for amblyopia in patients ages 4 to 18 (inclusive). The second will compare iCare to a standard of care for home-based CI therapy (pencil pushups) for convergence insufficiency patients ages 8 to 18 (inclusive). In the context of this study, the term iCare refers to either the amblyopia or CI video game module as appropriate for the respective study group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2017
CompletedFirst Posted
Study publicly available on registry
February 28, 2017
CompletedStudy Start
First participant enrolled
May 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedResults Posted
Study results publicly available
December 10, 2024
CompletedDecember 10, 2024
November 1, 2024
2.8 years
February 23, 2017
September 1, 2023
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Visual Acuity
Pre- to post-intervention change in best-corrected vision measured using a logMAR (Logarithm of the Minimum Angle of Resolution) chart, which consists of rows of letters of different sizes. The scale ranges from -0.3 (approximately 20/10 vision on the Snellen chart) to 1 (approximately 20/200 vision). Lower scores indicate better vision.
Pre- to post-intervention change in best-corrected vision (delta-logMAR) at 12 weeks
Positive Fusional Vergence (PFV) Base-Out Breakpoint (BOB)
Cover Testing procedures were followed by evaluation of PFV at near using base-out prisms. A single column of 20/30 letters of the Gulden Fixation stick was advanced towards the subject from the distance of 40cm from the subject's eyes, while the subject continued fusing the letters (keeping them single) while viewing them through a corresponding prism. The magnitude of the prism was increased (for break point) and subsequently decreased (for recovery point) at a rate of about 2∆ /second. The procedure was repeated 3 times and the blinded examiner recorded blur, break and recovery points in prism diopters (∆). Larger numbers are better.
Pre- to post-intervention change in BOB (delta-BOB) at 12 weeks
Secondary Outcomes (2)
Near Point of Convergence (NPC) at Break
Pre- to post-intervention change at 12 weeks
Convergence Insufficiency Symptom Survey (CISS)
Pre- to post-intervention change at 12 weeks
Study Arms (4)
Amblyopia standard of care group
ACTIVE COMPARATORA standard of care group will be prescribed patching for two or six hours per day, seven days per week. Standard of care group participants with best-corrected vision worse than 20/200 in their amblyopic eye will be prescribed six hours of patching daily, while participants whose best-corrected visual acuity is 20/200 or better will be prescribed two hours of patching daily.
Amblyopia iCare group
EXPERIMENTALParticipants assigned to an experimental group will play iCare vision therapy games for approximately 20 minutes per day, five days per week.
Convergence insufficiency standard of care group
ACTIVE COMPARATORA standard of care group for convergence insufficiency will perform pencil pushups for 20 minutes per day, five days per week.
Convergence insufficiency iCare group
EXPERIMENTALThe iCare experimental group for convergence insufficiency will be prescribed vision therapy gameplay for approximately 20 minutes per day, five days per week.
Interventions
The iCare product is an action video game designed to provide home-based vision therapy for non-strabismic amblyopia and convergence insufficiency in children as young as 4 years old. Participants assigned to an iCare group will play iCare vision therapy games for approximately 20 minutes per day, five days per week.
The amblyopia standard of care group will be prescribed patching for two or six hours per day, seven days per week. Standard of care group participants with best-corrected vision worse than 20/200 in their amblyopic eye will be prescribed six hours of patching daily
A dosage-matched CI standard of Care group will be prescribed pencil pushups for 20 minutes per day, five days per week.
Eligibility Criteria
You may qualify if:
- Age 4 to 18 (inclusive);
- Diagnosis of amblyopia associated with anisometropia;
- No amblyopia treatment (atropine, patching, vision therapy) in the past two weeks;
- Spectacles (if required) worn for at least 16 weeks, or demonstrated stability of visual acuity (\< 0.1 logMAR change by the same testing method measured on two exams at least four weeks apart);
- Visual acuity in the amblyopic eye of 20/40 or worse;
- Visual acuity in the fellow eye of 20/25 or better;
- Interocular difference ≥ 0.3 logMAR (3 logMAR chart lines);
- No myopia greater than -6.00D spherical equivalent in either eye;
- Demonstrate in-office ability to play the iCare training game under binocular condition
You may not qualify if:
- Prism in the refractive correction at time of enrollment;
- Previous intraocular or refractive surgery;
- Any treatment for amblyopia in the past two weeks;
- Down syndrome or cerebral palsy or other severe developmental delay that would interfere with treatment or evaluation;
- Heterotropia or heterophoria with a total ocular deviation \> 10∆ at near.
- Best-corrected visual acuity of ≥ 20/25 in each eye at distance and near;
- Exophoria at near at least 4∆ greater than at distance;
- Reduced positive fusional convergence at near (\< 20∆ or fails Sheard's criterion that the PFV measures less than twice the magnitude of the near phoria);
- Near point of convergence of ≥ 6 cm break;
- CI Symptom Survey Score of ≥ 16;
- No use of a plus add for near or base-in prism for at least two weeks preceding enrollment;
- Patient must be wearing appropriate refractive correction for at least two weeks prior to enrollment, if necessary;
- Demonstrate in-office ability to play the iCare training game under binocular conditions.
- ≥ 0.2 logMAR (2 line) difference in best-corrected visual acuity between the two eyes;
- Constant or intermittent exotropia at distance; constant exotropia at near;
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Barron Associates, Inc.lead
- University of North Dakotacollaborator
Study Sites (1)
Southern College of Optometry
Memphis, Tennessee, 38104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Richard Adams
- Organization
- Barron Associates, Inc.
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2017
First Posted
February 28, 2017
Study Start
May 7, 2019
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
December 10, 2024
Results First Posted
December 10, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share